This topic contains a solution. Click here to go to the answer

Author Question: The process by which a medication passing through the liver may be partially or completely ... (Read 128 times)

iveyjurea

  • Hero Member
  • *****
  • Posts: 555
The process by which a medication passing through the liver may be partially or completely inactivate many medications is known as:
 
  a. First-pass effect
  b. Prodrug effect
  c. Protein reservoir binding
  d. Plasma binding effect

Question 2

The heart is protected anteriorly by the:
 
  a. mediastinum.
  b. sternum.
  c. spinal column.
  d. 5th and 6th ribs.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

hugthug12

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

a
Rationale: a. Correct.
b. A prodrug is an inactive precursor of a drug prior to conversion to an active metabolite.
c. Protein reservoir binding occurs when a portion of a drug is bound to proteins but may be released for us at a later time.
d. Plasma binding occurs with proteins as described above in answer c.

Answer to Question 2

B





 

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Since 1988, the CDC has reported a 99% reduction in bacterial meningitis caused by Haemophilus influenzae, due to the introduction of the vaccine against it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library